cardiology

【Growth Process】

In the 1960s and 1970s, the Department of Internal Medicine in our hospital was established. The successive department directors are Huang Fengming, Yan Wanfang, Xu Jialian, Zhang Qiyuan and Wang Yiping. In 1993, the Department of Internal Medicine was divided into Internal Medicine One and Internal Medicine Two, and the department directors were Wang Yiping, Shen Baoding and Wang Guoliang respectively. In December 2006, the Department of Cardiovascular Medicine, a branch of the Department of Internal Medicine, was established. It shares the same ward with the Department of Gastroenterology and Hematology, and Zhou Feng serves as the department director. In 2009, with the opening of the hospital's new inpatient building, the hospital ushered in great development and the Department of Cardiology was established independently. In 1992, the first case of thrombolytic treatment for acute myocardial infarction was carried out (main developer: Wang Yiping). In 2006, the first temporary pacemaker implantation was carried out (main performers: He Zhengfei, Yu Jian). In 2007, the first St. Jude permanent pacemaker in Fuyang District was implanted (main developers: He Zhengfei, Yu Jian). In February 2013, the first coronary angiography in Fuyang was performed (main performers: He Zhengfei, Chen Zhiyun). On July 12, 2013, the first ICD in Fuyang was implanted (main developers: He Zhengfei, Chen Zhiyun). On October 27, 2014, the first CRT in Fuyang was implanted (main developer: Yu Jian). On May 11, 2015, the first electrophysiological examination and radiofrequency ablation of supraventricular tachycardia was carried out (main performers: Yu Jian and Liang Guiying). On July 16, 2015, the first radiofrequency ablation of atrial fibrillation was performed (main performers: Yu Jian and Liang Guiying). In 2016, we began to apply for the establishment of a chest pain center and independently performed emergency PCI for acute myocardial infarction. The number of emergency PCI surgeries has also increased from more than 30 per year at the beginning to more than 100 per year now. It saves the lives and health of a large number of myocardial infarction patients every year. In 2016, the first aortic balloon counterpulsation pump (IABP) pump was implanted in a patient with inferior wall myocardial infarction and massive right coronary thrombosis (main developers: He Zhengfei, Chen Zhiyun). In 2017, the first intravascular ultrasound examination (IVUS) was carried out, providing a more precise method for interventional treatment of coronary heart disease (main developers: He Zhengfei, Chen Zhiyun). On October 15, 2018, we successfully opened the anterior descending artery of a patient with recurrent ventricular fibrillation after myocardial infarction under cardiopulmonary resuscitation and interventional treatment, and successfully saved the patient. This event received widespread media attention. In November 2019, the chest pain center of our hospital successfully passed the standard chest pain center certification of the China Chest Pain Center Headquarters. Our hospital officially became the only chest pain center in Fuyang area that has passed the certification of the headquarters. This shows that our hospital has been recognized by superior departments in the diagnosis and treatment of chest pain patients, especially the diagnosis and treatment of acute coronary syndrome. In recent years, many heart surgeries have been completed with the support of ECOM. Interventional treatment of patients with sudden arrest. In January 2019, it passed the acceptance of Hangzhou’s key disciplines. In April 2023, a hypertension standard compliance center and a pan-vascular disease management center were established.

[Successive directors and head nurses]

Successive department directors: In 2009, Zhou Feng served as the director of the Department of Cardiology. In 2010, He Zhengfei served as the deputy director of the Department of Cardiology. In 2013, Chen Zhiyun served as the deputy director of the Department of Cardiology. In May 2018, Director Zhou Feng resigned as director of the department because he was approaching retirement, and Chen Zhiyun became the deputy director of the Department of Cardiology. Director, Director Zhou Feng serves as the director of the academic department. In May 2020, Sun Linggang served as deputy director of the Department of Cardiology and director of the cath lab. He served as the head nurse from 2006 to 2009, Li Guifen served as the head nurse from 2009 to 2011, Li Xiujuan served as the head nurse from 2012 to 2015, Jin Xuhua served as the head nurse from 2012 to January 2014, and Fang Zhihua served as the head nurse from March 2015. -In January 2019, Yang Xiaoyun was appointed as the head nurse. From January 2019 to April 2020, Yu Huaqin served as the head nurse of the Department of Cardiology. From May 2020 to present, Chen Xiaoping serves as the head nurse of the Department of Cardiology and the chief nurse of the Department of Internal Medicine.

【Current status of subject】

Cardiovascular medicine is a key discipline in Hangzhou. The department currently has 3 chief physicians, 6 deputy chief physicians, 4 attending physicians, 5 residents, and 7 postgraduate students. It is equipped with 59 beds, CCU and central ECG monitoring system. It has a well-equipped cardiac interventional treatment center. The center is equipped with a Philips large DSA machine, high-pressure syringes, aortic balloon counterpulsation pump, intravascular ultrasound (IVUS) system, three-dimensional electrophysiological navigation system (carto), electrophysiological recorder, multi-channel electrophysiological recorder, radio frequency Ablation machines, ventilators and other advanced equipment. Three major categories of interventional technologies: 1. Coronary angiography and stent implantation, including emergency PCI surgery for acute myocardial infarction, intravascular ultrasonography, and aortic balloon counterpulsation implantation. 2. Cardiac electrophysiological examination and radiofrequency ablation: including electrophysiological examination and radiofrequency ablation surgery for various arrhythmias such as supraventricular tachycardia, pre-excitation syndrome, ventricular premature syndrome, atrial fibrillation, etc. 3. Pacemaker implantation technology: including temporary pacemakers, single and dual chamber pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy triple chamber pacemakers (CRT) and other implants Enter surgery. The department focuses on coronary heart disease intervention, cardiac electrophysiological examination, radiofrequency ablation, and pacemaker implantation. In 2019, it passed the standard chest pain center certification of the China Chest Pain Center Headquarters and became the Fuyang District Acute Chest Pain Treatment Center. Since its establishment, the center has greatly improved the rescue level of acute and critical chest pain patients in Fuyang District, completing more than 100 emergency surgeries for acute myocardial infarction every year. , greatly saving the lives of patients with critical chest pain. At the same time, the subject undertakes the teaching tasks of Zhejiang University of Traditional Chinese Medicine. Comrade He Zhengfei was awarded the "Fuchun Chief Famous Doctor", Chen Zhiyun was awarded the "Fuchun Famous Doctor", the "Top Ten Doctors" in Fuyang District, and Sun Linggang was awarded the "Fuchun Medical Rookie".

【Diagnosis and treatment scope】

Including various common and difficult diseases in the cardiovascular department, such as hypertension, hyperlipidemia, coronary heart disease, heart failure, arrhythmia, congenital heart disease, etc.

【Technical Features】

It features cardiovascular interventional diagnosis and treatment, with three major categories of interventional technologies: 1. Coronary angiography and stent implantation, including emergency PCI surgery for acute myocardial infarction, intravascular ultrasonography, and aortic balloon counterpulsation implantation. 2. Cardiac electrophysiological examination and radiofrequency ablation: including electrophysiological examination and radiofrequency ablation surgery for various arrhythmias such as supraventricular tachycardia, pre-excitation syndrome, ventricular premature syndrome, atrial fibrillation, etc. 3. Pacemaker implantation technology: including temporary pacemakers, single and dual chamber pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy triple chamber pacemakers (CRT) and other implants Enter surgery. The department focuses on coronary heart disease intervention, cardiac electrophysiological examination, radiofrequency ablation, and pacemaker implantation. Among them, coronary heart disease intervention is the main direction. In-depth cooperation with Shaw Hospital, more than 1,000 cases of coronary angiography are completed every year, including more than 400 cases of PCI surgery, including more than 150 cases of emergency PCI for acute myocardial infarction. In 2019, it successfully passed the China Chest Pain Center Headquarters Standard Edition Chest Pain Center Certification. With the support of ECOM, interventional treatments for cardiac arrest and other critical myocardial infarction patients have been completed many times, and very good results have been achieved.

【Scientific research results】

The department has a doctoral workstation and a famous doctor's studio, presided over 1 Zhejiang Provincial Natural Science Project, presided over 1 Zhejiang Provincial Health and Health Commission project, completed 1 Zhejiang Provincial Health and Family Planning Commission scientific research project, and Hangzhou Science and Technology Bureau 1 project, Fuyang 1 project from the District Science and Technology Bureau and 2 projects from the Hangzhou Municipal Health and Family Planning Bureau. One provincial continuing education project is held every year. Published dozens of papers, including several SCI papers.